0 XP   0   0   0

Bayer AG NA










Financial Health of Bayer




Comparing to competitors in the Drug Manufacturers - Major industry




  Industry Rankings  


Richest
#2 / 12

Total Sales
#12 / 12

Making Money
#3 / 12

Working Efficiently
#12 / 12

Bayer AG NA
Buy, Hold or Sell?

Should you buy, hold or sell Bayer?

I guess you are interested in Bayer AG NA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Bayer

Let's start. I'm going to help you getting a better view of Bayer AG NA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Bayer AG NA even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Bayer AG NA is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Bayer AG NA. The closing price on 2022-11-28 was €55.81 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Bayer AG NA Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Bayer AG NA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bayer earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Bayer to the Drug Manufacturers - Major industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bayer AG NA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.2%+0.2%
TTM-5Y-3.7%+3.7%
5Y-3.7%10Y-3.7%0.0%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.8%-10.8%
TTM-10.8%-10.8%
YOY-0.2%14.8%-15.0%
5Y-3.7%12.2%-15.9%
10Y-3.7%11.9%-15.6%
1.1.2. Return on Assets

Shows how efficient Bayer is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bayer to the Drug Manufacturers - Major industry mean.
  • 0.5% Return on Assets means that Bayer generated €0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bayer AG NA:

  • The MRQ is 0.5%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.5%TTM1.0%-0.5%
TTM1.0%YOY0.0%+1.0%
TTM1.0%5Y0.2%+0.8%
5Y0.2%10Y0.2%0.0%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5%1.8%-1.3%
TTM1.0%2.3%-1.3%
YOY0.0%3.0%-3.0%
5Y0.2%3.0%-2.8%
10Y0.2%2.7%-2.5%
1.1.3. Return on Equity

Shows how efficient Bayer is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bayer to the Drug Manufacturers - Major industry mean.
  • 1.8% Return on Equity means Bayer generated €0.02 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bayer AG NA:

  • The MRQ is 1.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.8%TTM3.8%-2.0%
TTM3.8%YOY-0.1%+3.9%
TTM3.8%5Y0.7%+3.1%
5Y0.7%10Y0.7%0.0%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%2.5%-0.7%
TTM3.8%3.9%-0.1%
YOY-0.1%4.4%-4.5%
5Y0.7%4.2%-3.5%
10Y0.7%4.0%-3.3%

1.2. Operating Efficiency of Bayer AG NA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bayer is operating .

  • Measures how much profit Bayer makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bayer to the Drug Manufacturers - Major industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bayer AG NA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY5.6%-5.6%
TTM-5Y2.5%-2.5%
5Y2.5%10Y2.5%0.0%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.7%-29.7%
TTM-11.5%-11.5%
YOY5.6%11.7%-6.1%
5Y2.5%12.0%-9.5%
10Y2.5%11.0%-8.5%
1.2.2. Operating Ratio

Measures how efficient Bayer is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Bayer AG NA:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.391-0.391
TTM-5Y0.263-0.263
5Y0.26310Y0.2630.000
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.475-0.475
TTM-0.425-0.425
YOY0.3910.731-0.340
5Y0.2630.943-0.680
10Y0.2630.983-0.720

1.3. Liquidity of Bayer AG NA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bayer is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • A Current Ratio of 1.16 means the company has €1.16 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Bayer AG NA:

  • The MRQ is 1.158. The company is just able to pay all its short-term debts.
  • The TTM is 1.169. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.158TTM1.169-0.011
TTM1.169YOY1.120+0.048
TTM1.1695Y1.139+0.029
5Y1.13910Y1.1390.000
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1581.824-0.666
TTM1.1691.800-0.631
YOY1.1201.807-0.687
5Y1.1391.305-0.166
10Y1.1391.218-0.079
1.3.2. Quick Ratio

Measures if Bayer is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bayer to the Drug Manufacturers - Major industry mean.
  • A Quick Ratio of 0.44 means the company can pay off €0.44 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bayer AG NA:

  • The MRQ is 0.445. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.502. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.445TTM0.502-0.057
TTM0.502YOY0.873-0.371
TTM0.5025Y0.723-0.222
5Y0.72310Y0.7230.000
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4451.248-0.803
TTM0.5021.200-0.698
YOY0.8731.151-0.278
5Y0.7230.836-0.113
10Y0.7230.750-0.027

1.4. Solvency of Bayer AG NA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bayer assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bayer to Drug Manufacturers - Major industry mean.
  • A Debt to Asset Ratio of 0.73 means that Bayer assets are financed with 73.3% credit (debt) and the remaining percentage (100% - 73.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bayer AG NA:

  • The MRQ is 0.733. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.733. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.733TTM0.7330.000
TTM0.733YOY0.729+0.004
TTM0.7335Y0.732+0.001
5Y0.73210Y0.7320.000
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7330.415+0.318
TTM0.7330.419+0.314
YOY0.7290.429+0.300
5Y0.7320.455+0.277
10Y0.7320.431+0.301
1.4.2. Debt to Equity Ratio

Measures if Bayer is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bayer to the Drug Manufacturers - Major industry mean.
  • A Debt to Equity ratio of 274.7% means that company has €2.75 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bayer AG NA:

  • The MRQ is 2.747. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.747. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.747TTM2.7470.000
TTM2.747YOY2.693+0.054
TTM2.7475Y2.731+0.017
5Y2.73110Y2.7310.000
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7470.675+2.072
TTM2.7470.698+2.049
YOY2.6930.738+1.955
5Y2.7310.840+1.891
10Y2.7310.814+1.917

2. Market Valuation of Bayer AG NA

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Bayer generates.

  • Above 15 is considered overpriced but always compare Bayer to the Drug Manufacturers - Major industry mean.
  • A PE ratio of 7.07 means the investor is paying €7.07 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bayer AG NA:

  • The EOD is 8.274. Very good. +2
  • The MRQ is 7.065. Very good. +2
  • The TTM is -0.882. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD8.274MRQ7.065+1.209
MRQ7.065TTM-0.882+7.947
TTM-0.882YOY17.636-18.518
TTM-0.8825Y0.133-1.015
5Y0.13310Y0.1330.000
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
EOD8.27473.229-64.955
MRQ7.06566.328-59.263
TTM-0.88260.797-61.679
YOY17.63633.289-15.653
5Y0.13360.412-60.279
10Y0.13364.422-64.289
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Bayer.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Bayer AG NA:

  • The MRQ is 4.571. Seems overpriced? -1
  • The TTM is 2.938. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ4.571TTM2.938+1.632
TTM2.938YOY23.775-20.837
TTM2.9385Y13.357-10.418
5Y13.35710Y13.3570.000
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ4.571-0.235+4.806
TTM2.9380.137+2.801
YOY23.7750.124+23.651
5Y13.3570.232+13.125
10Y13.3570.222+13.135

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bayer is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • A PB ratio of 0.12 means the investor is paying €0.12 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Bayer AG NA:

  • The EOD is 0.145. Very good. +2
  • The MRQ is 0.124. Very good. +2
  • The TTM is 0.139. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.145MRQ0.124+0.021
MRQ0.124TTM0.139-0.015
TTM0.139YOY1.049-0.910
TTM0.1395Y1.169-1.030
5Y1.16910Y1.1690.000
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
EOD0.1451.495-1.350
MRQ0.1241.439-1.315
TTM0.1391.890-1.751
YOY1.0492.460-1.411
5Y1.1691.972-0.803
10Y1.1692.221-1.052
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Bayer AG NA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0%93.742-100%42.690-100%42.690-100%
Book Value Growth---0.038-0.0380%-0.044+16%-0.041+8%-0.041+8%
Book Value Per Share--384.213384.2130%144.716+165%236.107+63%236.107+63%
Book Value Per Share Growth----0%-0.3060%-0.1530%-0.1530%
Current Ratio--1.1581.169-1%1.120+3%1.139+2%1.139+2%
Debt To Asset Ratio--0.7330.7330%0.729+1%0.732+0%0.732+0%
Debt To Equity Ratio--2.7472.7470%2.693+2%2.731+1%2.731+1%
Dividend Per Share--0.04918.227-100%3.317-99%9.666-99%9.666-99%
Dividend Per Share Growth---490.500-122.376-75%-8.163-98%-73.427-85%-73.427-85%
Eps--6.74514.515-54%0.838+705%6.733+0%6.733+0%
Eps Growth--1.546-2.231+244%0.507+205%-0.862+156%-0.862+156%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0.0020%-0.0370%-0.0370%
Operating Margin----0%0.056-100%0.025-100%0.025-100%
Operating Ratio----0%0.391-100%0.263-100%0.263-100%
Pb Ratio0.145+15%0.1240.139-11%1.049-88%1.169-89%1.169-89%
Pe Ratio8.274+15%7.065-0.882+112%17.636-60%0.133+5206%0.133+5206%
Peg Ratio--4.5712.938+56%23.775-81%13.357-66%13.357-66%
Price Per Share55.805+15%47.65353.391-11%50.190-5%51.959-8%51.959-8%
Price To Total Gains Ratio1129.387+15%964.396242.807+297%-0.653+100%108.213+791%108.213+791%
Profit Growth--156.664-233.528+249%967.187-84%366.830-57%366.830-57%
Quick Ratio--0.4450.502-11%0.873-49%0.723-39%0.723-39%
Return On Assets--0.0050.010-54%0.000+3315%0.002+135%0.002+135%
Return On Equity--0.0180.038-54%-0.001+105%0.007+164%0.007+164%
Total Gains Per Share--0.04918.227-100%97.058-100%52.356-100%52.356-100%
Total Gains Per Share Growth---490.500-126.115-74%0.684-71774%-62.715-87%-62.715-87%
Usd Book Value--32291134600.00032291134600.0000%32859808650.000-2%32569718266.667-1%32569718266.667-1%
Usd Book Value Change Per Share----0%97.322-100%44.321-100%44.321-100%
Usd Book Value Per Share--398.890398.8900%150.244+165%245.126+63%245.126+63%
Usd Dividend Per Share--0.05118.923-100%3.443-99%10.035-99%10.035-99%
Usd Eps--7.00215.069-54%0.869+705%6.990+0%6.990+0%
Usd Price Per Share57.937+15%49.47355.431-11%52.107-5%53.944-8%53.944-8%
Usd Profit--566857200.0001219885000.000-54%38153850.000+1386%242592733.333+134%242592733.333+134%
Usd Revenue----0%11149748900.000-100%5936658311.111-100%5936658311.111-100%
Usd Total Gains Per Share--0.05118.923-100%100.766-100%54.356-100%54.356-100%
 EOD+2 -3MRQTTM+5 -16YOY+16 -165Y+15 -1710Y+15 -17

3.2. Fundamental Score

Let's check the fundamental score of Bayer AG NA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-158.274
Price to Book Ratio (EOD)Between0-10.145
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.445
Current Ratio (MRQ)Greater than11.158
Debt to Asset Ratio (MRQ)Less than10.733
Debt to Equity Ratio (MRQ)Less than12.747
Return on Equity (MRQ)Greater than0.150.018
Return on Assets (MRQ)Greater than0.050.005
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Bayer AG NA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose55.546
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in EUR. All numbers in thousands.

Summary
 As reported
Total Liabilities -
Total Stockholder Equity+ -
Total Assets = -

Assets

Total Assets-
Total Current Assets38,412,000
Long-term Assets38,412,000
Total Current Assets
Net Receivables 14,747,000
Inventory 12,791,000
Other Current Assets 1,800,000
Total Current Assets  (as reported)38,412,000
Total Current Assets  (calculated)29,338,000
+/- 9,074,000
Long-term Assets
Property Plant Equipment 13,921,000
Long-term Assets  (as reported)0
Long-term Assets  (calculated)13,921,000
+/- 13,921,000

Liabilities & Shareholders' Equity

Total Current Liabilities33,172,000
Long-term Liabilities-
Total Stockholder Equity-
Total Current Liabilities
Accounts payable 6,549,000
Other Current Liabilities 21,292,000
Total Current Liabilities  (as reported)33,172,000
Total Current Liabilities  (calculated)27,841,000
+/- 5,331,000
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)0
+/-0
Other
Net Tangible Assets -28,177,000



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
119,520,000
116,763,000
118,777,000
114,427,000
116,549,000
0
0
0
0
0000116,549,000114,427,000118,777,000116,763,000119,520,000
   > Total Current Assets 
39,339,000
35,677,000
35,797,000
32,451,000
31,945,000
32,578,000
38,246,000
39,550,000
38,412,000
38,412,00039,550,00038,246,00032,578,00031,945,00032,451,00035,797,00035,677,00039,339,000
       Cash And Cash Equivalents 
5,067,000
4,191,000
5,550,000
3,389,000
4,316,000
0
0
0
0
00004,316,0003,389,0005,550,0004,191,0005,067,000
       Short-term Investments 
10,473,000
7,940,000
3,762,000
3,109,000
3,903,000
0
0
0
0
00003,903,0003,109,0003,762,0007,940,00010,473,000
       Net Receivables 
10,161,000
9,555,000
12,973,000
15,796,000
13,052,000
12,980,000
17,824,000
18,385,000
14,747,000
14,747,00018,385,00017,824,00012,980,00013,052,00015,796,00012,973,0009,555,00010,161,000
       Inventory 
10,452,000
10,961,000
10,457,000
10,125,000
10,644,000
11,314,000
10,869,000
11,371,000
12,791,000
12,791,00011,371,00010,869,00011,314,00010,644,00010,125,00010,457,00010,961,00010,452,000
       Other Current Assets 
43,000
113,000
135,000
32,000
30,000
545,000
1,359,000
1,600,000
1,800,000
1,800,0001,600,0001,359,000545,00030,00032,000135,000113,00043,000
   > Long-term Assets 000000000
       Property Plant Equipment 
11,502,000
11,710,000
11,810,000
11,830,000
12,036,000
12,688,000
12,786,000
13,275,000
13,921,000
13,921,00013,275,00012,786,00012,688,00012,036,00011,830,00011,810,00011,710,00011,502,000
       Goodwill 
35,143,000
36,395,000
37,224,000
36,965,000
39,421,000
0
0
0
0
000039,421,00036,965,00037,224,00036,395,00035,143,000
       Intangible Assets 
25,433,000
25,416,000
26,430,000
25,308,000
24,970,000
0
0
0
0
000024,970,00025,308,00026,430,00025,416,00025,433,000
> Total Liabilities 
88,193,000
86,240,000
84,189,000
84,038,000
85,446,000
0
0
0
0
000085,446,00084,038,00084,189,00086,240,00088,193,000
   > Total Current Liabilities 
35,790,000
36,765,000
28,932,000
27,926,000
28,727,000
29,403,000
31,019,000
33,643,000
33,172,000
33,172,00033,643,00031,019,00029,403,00028,727,00027,926,00028,932,00036,765,00035,790,000
       Accounts payable 
0
0
0
5,118,000
5,587,000
6,792,000
5,847,000
6,097,000
6,549,000
6,549,0006,097,0005,847,0006,792,0005,587,0005,118,000000
       Other Current Liabilities 
0
0
0
19,100,000
18,348,000
14,715,000
19,273,000
20,973,000
21,292,000
21,292,00020,973,00019,273,00014,715,00018,348,00019,100,000000
   > Long-term Liabilities 000000000
       Other Liabilities 
0
0
0
19,259,000
19,575,000
21,189,000
20,508,000
18,886,000
16,911,000
16,911,00018,886,00020,508,00021,189,00019,575,00019,259,000000
       Deferred Long Term Liability 
0
0
0
0
0
4,312,000
0
0
0
0004,312,00000000
> Total Stockholder Equity
31,327,000
30,523,000
34,588,000
30,389,000
31,103,000
0
0
0
0
000031,103,00030,389,00034,588,00030,523,00031,327,000
   Common Stock
2,515,000
2,515,000
2,515,000
2,515,000
2,515,000
2,515,000
2,515,000
2,515,000
2,515,000
2,515,0002,515,0002,515,0002,515,0002,515,0002,515,0002,515,0002,515,0002,515,000
   Retained Earnings 
10,551,000
9,747,000
13,812,000
9,613,000
10,327,000
13,345,000
0
0
0
00013,345,00010,327,0009,613,00013,812,0009,747,00010,551,000
   Capital Surplus 
18,261,000
18,261,000
18,261,000
18,261,000
18,261,000
0
0
0
0
000018,261,00018,261,00018,261,00018,261,00018,261,000
   Treasury Stock000000000
   Other Stockholders Equity 
0
0
0
27,874,000
28,588,000
17,160,000
34,922,000
35,504,000
38,757,000
38,757,00035,504,00034,922,00017,160,00028,588,00027,874,000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue-
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense--
Operating Income-0
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense-0
 
Net Interest Income (+$)
Interest Income-
Interest Expense-0
Net Interest Income-0
 
Pretax Income (+$)
Operating Income-
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-0
EBIT - interestExpense = 7,152,000
1,024,000
0
Interest Expense0
Earnings Before Interest and Taxes (ebit)7,152,0000
Earnings Before Interest and Taxes (ebitda)-
 
After tax Income (+$)
Income Before Tax-
Tax Provision--
Net Income From Continuing Ops-0
Net Income-
Net Income Applicable To Common Shares1,000,000
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses27,000
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
MAG.TO
2 minutes ago

I found you a Golden Cross on the daily chart of MAG.TO.

MAG.TO Daily Candlestick Chart
L.TO
3 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of L.TO.

L.TO Daily Candlestick Chart
HUT.TO
5 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of HUT.TO.

HUT.TO Daily Candlestick Chart
GTMS.TO
9 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of GTMS.TO.

GTMS.TO Daily Candlestick Chart
PNPN.V
11 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PNPN.V.

PNPN.V Daily Candlestick Chart
YFI.V
11 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of YFI.V.

YFI.V Daily Candlestick Chart
NCP.TO
17 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of NCP.TO.

NCP.TO Daily Candlestick Chart
XDU.TO
17 minutes ago

I found you a Golden Cross on the daily chart of XDU.TO.

XDU.TO Daily Candlestick Chart
MXG.TO
18 minutes ago

I found you a Death Cross on the daily chart of MXG.TO.

MXG.TO Daily Candlestick Chart
ZDM.TO
22 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ZDM.TO.

ZDM.TO Daily Candlestick Chart
TIXT.TO
27 minutes ago

I found you a Death Cross on the daily chart of TIXT.TO.

TIXT.TO Daily Candlestick Chart
ZORDIX-B.ST
32 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ZORDIX-B.ST.

ZORDIX-B.ST Daily Candlestick Chart
RCSL3.SA
35 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of RCSL3.SA.

RCSL3.SA Daily Candlestick Chart
POSI3.SA
35 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of POSI3.SA.

POSI3.SA Daily Candlestick Chart
PETR3.SA
35 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PETR3.SA.

PETR3.SA Daily Candlestick Chart
LREN3.SA
37 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of LREN3.SA.

LREN3.SA Daily Candlestick Chart
HGRE11.SA
37 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HGRE11.SA.

HGRE11.SA Daily Candlestick Chart
HAPV3.SA
38 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HAPV3.SA.

HAPV3.SA Daily Candlestick Chart
JAX.V
45 minutes ago

I found you a MACD Bearish Hidden Divergence on the daily chart of JAX.V.

JAX.V Daily Candlestick Chart
OLY.TO
46 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OLY.TO.

OLY.TO Daily Candlestick Chart
ILSPLN.FOREX
3 hours ago

I found you a Death Cross on the daily chart of ILSPLN.FOREX.

ILSPLN.FOREX Daily Candlestick Chart
MYRCNH.FOREX
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MYRCNH.FOREX.

MYRCNH.FOREX Daily Candlestick Chart
CNHTWD.FOREX
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CNHTWD.FOREX.

CNHTWD.FOREX Daily Candlestick Chart
MCRNT.TA
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of MCRNT.TA.

MCRNT.TA Daily Candlestick Chart
TTAM.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TTAM.TA.

TTAM.TA Daily Candlestick Chart